822 related articles for article (PubMed ID: 11424117)
21. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
[TBL] [Abstract][Full Text] [Related]
22. Vaccination against hepatitis B: comparison of three different vaccination schedules.
Jilg W; Schmidt M; Deinhardt F
J Infect Dis; 1989 Nov; 160(5):766-9. PubMed ID: 2530289
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another.
Bush LM; Moonsammy GI; Boscia JA
Vaccine; 1991 Nov; 9(11):807-9. PubMed ID: 1836921
[TBL] [Abstract][Full Text] [Related]
24. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.
Wood RC; MacDonald KL; White KE; Hedberg CW; Hanson M; Osterholm MT
JAMA; 1993 Dec 22-29; 270(24):2935-9. PubMed ID: 8254853
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of a 'pre-S2 plus S' hepatitis B vaccine in healthy adults.
Katkov WN; Watkins E; DeMelia HC; Dienstag JL
J Viral Hepat; 1994; 1(1):79-83. PubMed ID: 8790563
[TBL] [Abstract][Full Text] [Related]
27. Preclinical evaluation of a two-dose vaccination schedule of recombinant Hansenula polymorpha hepatitis B vaccine in animals.
Li J; Zhang D; Ma R; Yang X; Wang X; Li C; Zhang S; Xue H; Zhao K; Zhuang H
Hum Vaccin Immunother; 2013 Apr; 9(4):736-43. PubMed ID: 23370192
[TBL] [Abstract][Full Text] [Related]
28. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
31. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
32. [Adaptability of the anti-hepatitis-B vaccine Recombivax HB to the Piazza protocol for the mass vaccination of newborn infants].
Piazza M; Abrescia N; Picciotto L; Cotugno M; Vegnente A; Iorio R; Cimmino L
Boll Soc Ital Biol Sper; 1992 Jul; 68(7):483-9. PubMed ID: 1482565
[TBL] [Abstract][Full Text] [Related]
33. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
[TBL] [Abstract][Full Text] [Related]
35. Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial.
Chaiwarith R; Praparattanapan J; Kotarathititum W; Wipasa J; Chaiklang K; Supparatpinyo K
AIDS Res Ther; 2019 Nov; 16(1):33. PubMed ID: 31711528
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates.
Bassily S; Kotkat A; Gray G; Hyams KC; Brown FM; Imam IZ; Arthur R
Am J Trop Med Hyg; 1995 Oct; 53(4):419-22. PubMed ID: 7485697
[TBL] [Abstract][Full Text] [Related]
37. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders.
Goldwater PN
Vaccine; 1997 Mar; 15(4):353-6. PubMed ID: 9141204
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers.
Williams JL; Christensen CJ; McMahon BJ; Bulkow LR; Cagle HH; Mayers JS; Zanis CL; Parkinson AJ; Margolis HS
Vaccine; 2001 Jul; 19(28-29):4081-5. PubMed ID: 11427285
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B vaccine booster dose: low-dose recombinant hepatitis B vaccines as a booster dose.
Bryan JP; MacArthy P; Rudock A; Fogarty JP; Dowd H; Legters LJ; Perine PL
Am J Infect Control; 1997 Jun; 25(3):215-22. PubMed ID: 9202817
[TBL] [Abstract][Full Text] [Related]
40. Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-responders to primary immunization.
Chiaramonte M; Ngatchu T; Majori S; Baldo V; Moschen ME; Renzulli G; Trivello R
Scand J Gastroenterol; 1995 Jun; 30(6):601-3. PubMed ID: 7569770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
